本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

11.39
-0.0400-0.35%
盘后11.420.0300+0.26%18:52 EDT
成交量:144.62万
成交额:1,643.15万
市值:12.73亿
市盈率:-7.30
高:11.48
开:11.34
低:11.22
收:11.43
数据加载中...
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]